Your browser doesn't support javascript.
loading
Biallelic VARS variants cause developmental encephalopathy with microcephaly that is recapitulated in vars knockout zebrafish.
Siekierska, Aleksandra; Stamberger, Hannah; Deconinck, Tine; Oprescu, Stephanie N; Partoens, Michèle; Zhang, Yifan; Sourbron, Jo; Adriaenssens, Elias; Mullen, Patrick; Wiencek, Patrick; Hardies, Katia; Lee, Jeong-Soo; Giong, Hoi-Khoanh; Distelmaier, Felix; Elpeleg, Orly; Helbig, Katherine L; Hersh, Joseph; Isikay, Sedat; Jordan, Elizabeth; Karaca, Ender; Kecskes, Angela; Lupski, James R; Kovacs-Nagy, Reka; May, Patrick; Narayanan, Vinodh; Pendziwiat, Manuela; Ramsey, Keri; Rangasamy, Sampathkumar; Shinde, Deepali N; Spiegel, Ronen; Timmerman, Vincent; von Spiczak, Sarah; Helbig, Ingo; Weckhuysen, Sarah; Francklyn, Christopher; Antonellis, Anthony; de Witte, Peter; De Jonghe, Peter.
Afiliação
  • Siekierska A; Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, 3000, Belgium.
  • Stamberger H; Neurogenetics Group, Center for Molecular Neurology, VIB, University of Antwerp, Antwerp, 2610, Belgium.
  • Deconinck T; Institute Born Bunge, University of Antwerp, Antwerp, 2610, Belgium.
  • Oprescu SN; Department of Neurology, Antwerp University Hospital, Antwerp, 2650, Belgium.
  • Partoens M; Neurogenetics Group, Center for Molecular Neurology, VIB, University of Antwerp, Antwerp, 2610, Belgium.
  • Zhang Y; Institute Born Bunge, University of Antwerp, Antwerp, 2610, Belgium.
  • Sourbron J; Department of Human Genetics, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Adriaenssens E; Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, 3000, Belgium.
  • Mullen P; Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, 3000, Belgium.
  • Wiencek P; Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, 3000, Belgium.
  • Hardies K; Institute Born Bunge, University of Antwerp, Antwerp, 2610, Belgium.
  • Lee JS; Peripheral Neuropathy Research Group, Department of Biomedical Sciences, University of Antwerp, Antwerp, 2610, Belgium.
  • Giong HK; Department of Biochemistry, University of Vermont, Burlington, VT, 05405, USA.
  • Distelmaier F; Department of Biochemistry, University of Vermont, Burlington, VT, 05405, USA.
  • Elpeleg O; Neurogenetics Group, Center for Molecular Neurology, VIB, University of Antwerp, Antwerp, 2610, Belgium.
  • Helbig KL; Institute Born Bunge, University of Antwerp, Antwerp, 2610, Belgium.
  • Hersh J; Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
  • Isikay S; KRIBB School, University of Science and Technology, Daejeon, 34141, Republic of Korea.
  • Jordan E; Dementia DTC R&D Convergence Program, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Karaca E; Disease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
  • Kecskes A; KRIBB School, University of Science and Technology, Daejeon, 34141, Republic of Korea.
  • Lupski JR; Dementia DTC R&D Convergence Program, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
  • Kovacs-Nagy R; Department of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Heinrich-Heine-University Düsseldorf, Düsseldorf, 40225, Germany.
  • May P; Monique and Jacques Roboh Department of Genetic Research, Hadassah-Hebrew University Medical Center, Jerusalem, 01120, Israel.
  • Narayanan V; Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
  • Pendziwiat M; Department of Pediatrics, Medicine, University of Louisville School of Medicine, 571S Floyd Street, Louisville, Kentucky, 40202, USA.
  • Ramsey K; Department of Physiotherapy and Rehabilitation, Hasan Kalyoncu University, School of Health Sciences, Gaziantep, 27410, Turkey.
  • Rangasamy S; The Ohio State University Division of Human Genetics, Department of Internal Medicine, 460 W 12th Ave, Columbus, Ohio, 43210, USA.
  • Shinde DN; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Spiegel R; Department of Genetics, University of Alabama, Birmingham, AL, 35233, USA.
  • Timmerman V; Laboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, 3000, Belgium.
  • von Spiczak S; Department of Pharmacology and Pharmacotherapy, University of Pecs, Pecs, 7622, Hungary.
  • Helbig I; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
  • Weckhuysen S; Texas Children's Hospital, Houston, TX, 77030, USA.
  • Francklyn C; Institute of Human Genetics, Technische Universität München, München, 81675, Germany.
  • Antonellis A; Luxembourg Center for Systems Biomedicine, University Luxembourg, Esch-sur-Alzette, 4365, Luxembourg.
  • de Witte P; Center for Rare Childhood Disorders, The Translational Genomics Research Institute, Phoenix, AZ, 85004, USA.
  • De Jonghe P; Department of Neuropediatrics, Christian-Albrechts-University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, 24105, Germany.
Nat Commun ; 10(1): 708, 2019 02 12.
Article em En | MEDLINE | ID: mdl-30755616
ABSTRACT
Aminoacyl tRNA synthetases (ARSs) link specific amino acids with their cognate transfer RNAs in a critical early step of protein translation. Mutations in ARSs have emerged as a cause of recessive, often complex neurological disease traits. Here we report an allelic series consisting of seven novel and two previously reported biallelic variants in valyl-tRNA synthetase (VARS) in ten patients with a developmental encephalopathy with microcephaly, often associated with early-onset epilepsy. In silico, in vitro, and yeast complementation assays demonstrate that the underlying pathomechanism of these mutations is most likely a loss of protein function. Zebrafish modeling accurately recapitulated some of the key neurological disease traits. These results provide both genetic and biological insights into neurodevelopmental disease and pave the way for further in-depth research on ARS related recessive disorders and precision therapies.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valina-tRNA Ligase / Encefalopatias / Microcefalia Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Valina-tRNA Ligase / Encefalopatias / Microcefalia Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article